Carbapenem
Top View
- Antibiotics Currently in Clinical Development Note: This Data Visualization Was Updated in May 2017 with New Data
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused By
- Treatment of Carbapenem Resistant Gram Negative Infections
- Beta-Lactam Allergy Tip Sheet
- Piperacillin-Tazobactam Use in Scottish Acute Hospitals
- Shionogi Briefing Document
- Zac4943-2Ch105t.Pdf
- Piperacillin–Tazobactam As Alternative to Carbapenems for ICU Patients
- Piperacillin-Tazobactam Use in Scottish Acute Hospitals
- SVARM|2008 Swedish Veterinary Antimicrobial Resistance Monitoring 2 SVARM|2008
- Penicillin Allergy Cross-‐Reactivity • Roughly 10% of the Population
- Antimicrobial Prescribing: Cefiderocol
- Molecular Diversity of Extended-Spectrum Β-Lactamases and Carbapenemases, and Antimicrobial Resistance Teiji Sawa1* , Kunihiko Kooguchi2 and Kiyoshi Moriyama3
- Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and Its Newer Rela Ves
- Consecutive Radical S-Adenosylmethionine Methylations Form the Ethyl Side Chain in Thienamycin Biosynthesis
- Antibiotic Consumption in Hospitalized Children at the University Clinic for Pediatric Diseases – Skopje
- Joint Report on Human and Animal Antibiotic Use, Sales and Resistance, 2013
- Comparative Antimicrobial Activity of Hp404 Peptide and Its Analogs Against Acinetobacter Baumannii